These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12237737)

  • 1. Blood substitutes and oxygen therapeutics: an overview and current status.
    Jahr JS; Nesargi SB; Lewis K; Johnson C
    Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Oxygen Carriers.
    Malchesky PS
    Artif Organs; 2017 Apr; 41(4):311. PubMed ID: 28397404
    [No Abstract]   [Full Text] [Related]  

  • 5. Perfluorocarbons: future clinical possibilities.
    Clark MC; Weiman DS; Pate JW; Gir S
    J Invest Surg; 1997; 10(6):357-65. PubMed ID: 9654392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of oxygen carriers ('blood substitutes'): 2006.
    Winslow RM
    Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial oxygen carriers -- a critical analysis of current developments].
    Dinkelmann S; Northoff H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):47-54. PubMed ID: 12522731
    [No Abstract]   [Full Text] [Related]  

  • 8. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.
    Spence RK
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen carriers ("blood substitutes").
    Topfer LA; Hailey D
    Issues Emerg Health Technol; 2001 Jul; (21):1-6. PubMed ID: 11776287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perflubron emulsion (Oxygent(tm)): a temporary intravenous oxygen carrier.
    Keipert PE
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S104-6. PubMed ID: 11753711
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood substitutes as pharmacotherapies in clinical practice.
    Jahr JS; Walker V; Manoochehri K
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorocarbon blood substitutes in Russia.
    Obraztsov VV
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1019-27. PubMed ID: 7849906
    [No Abstract]   [Full Text] [Related]  

  • 13. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current aspects in red blood cell substitutes].
    Wang Y; Pan J; Yu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping with artificial oxygen carriers: an update.
    Schumacher YO; Ashenden M
    Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?
    Alayash AI
    Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28054978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
    Winslow RM
    Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes.
    Tao Z; Ghoroghchian PP
    Trends Biotechnol; 2014 Sep; 32(9):466-73. PubMed ID: 24929580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK; Levine EM; Waxman K
    Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemoglobin substitutes.
    Anbari KK; Garino JP; Mackenzie CF
    Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S76-82. PubMed ID: 15168238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.